You are here

Increased toxicities from targeted cancer treatments

Interview with Paolo Bossi, MD, recorded at ESMO, September 2014.

Interview with Paolo Bossi, MD, recorded at ESMO, September 2014.

Oncologists are employing more and more targeted therapies and are facing symptoms that they are not accustomed to observe. In this interview Dr. Paolo Bossi is giving answers to some important questions, e.g.: Which are the major difficulties a physician faces when assessing patients’ symptoms? What is the impact of new targeted therapies on patients’ quality of life? Are there any worrisome symptoms that could have a greater impact on the quality of life? Dr. Bossi’s take-home message: Listen to the patient, use new instruments for assessing symptoms, and inform the patient about acute and late toxicities.

Paolo Bossi, MD, is Medical Oncologist at the National Cancer Institute, Milan, Italy.

Search this site

Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

NEW! Free access to the digital version of a new publication in Cancer Supportive Care

Cancer cachexia: mechanisms and progress in treatment

Authors: Egidio Del Fabbro, Kenneth Fearon, Florian Strasser

This book was supported by an educational grant from Helsinn Healthcare SA.

Featured videos

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo